-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PQNENiev2TDnMnJ9KGxrb2g7wEQKACA3u467KI19J0DJzNXlzJ/fII+YlWFmxn3l YfPpm8RuKb6dwGnKJBgvIg== /in/edgar/work/20000707/0000912057-00-031153/0000912057-00-031153.txt : 20000920 0000912057-00-031153.hdr.sgml : 20000920 ACCESSION NUMBER: 0000912057-00-031153 CONFORMED SUBMISSION TYPE: 424B5 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20000707 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GENOME THERAPEUTICS CORP CENTRAL INDEX KEY: 0000356830 STANDARD INDUSTRIAL CLASSIFICATION: [2835 ] IRS NUMBER: 042297484 STATE OF INCORPORATION: MA FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: 424B5 SEC ACT: SEC FILE NUMBER: 333-32614 FILM NUMBER: 669448 BUSINESS ADDRESS: STREET 1: 1OO BEAVER ST CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 7813982300 MAIL ADDRESS: STREET 1: 100 BEAVER STREET CITY: WALTHAM STATE: MA ZIP: 02453 FORMER COMPANY: FORMER CONFORMED NAME: COLLABORATIVE RESEARCH INC DATE OF NAME CHANGE: 19920703 424B5 1 a424b5.txt 424(B)(5) FILED PURSUANT TO RULE 424(b)(5) FILE NO. 333-32614 PRICING SUPPLEMENT NO. 4 DATED JULY 7, 2000 (TO PROSPECTUS DATED JUNE 21, 2000). 373,000 SHARES GENOME THERAPEUTICS CORP. COMMON STOCK ------------------------ On July 5, 2000, we sold 148,000 shares of our common stock, par value $0.10 per share (the "Common Stock"), at a weighted average price of $30.4101 per share. On July 7, 2000, we sold 225,000 shares of Common Stock at a weighted average price of $27.0269 per share. Each of these sales was conducted through our agent, Tucker Anthony Incorporated, in transactions effected through the Nasdaq National Market. Gross Proceeds to Genome Therapeutics Corp. ................ $10,581,747.00 Commission to Tucker Anthony................................ $ 211,709.00 Net Proceeds to Genome Therapeutics Corp. .................. $10,370,038.00 On July 7, 2000 the last reported sales price of the Common Stock on the Nasdaq National Market was................... $ 26.00
------------------------ Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense. -----END PRIVACY-ENHANCED MESSAGE-----